REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study

Trial Identifier: ZS-007
Sponsor: ZS Pharma, Inc.
NCTID:: NCT02607085
Start Date: October 2015
Primary Completion Date: April 2016
Study Completion Date: May 2016
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
USA, Alabama Montgomery, Alabama, USA, 36106
USA, Michigan Detroit, Michigan, USA, 48202
USA, Michigan Royal Oak, Michigan, USA, 48073
USA, Missouri Kansas City, Missouri, USA, 64111
USA, Missouri St. Louis, Missouri, USA, 63110
USA, NY Stony Brook, NY, USA, 11794
USA, Ohio Columbus, Ohio, USA, 43210
USA, Texas Temple, Texas, USA, 76508